One of the ways to administrate hepatitis B vaccination is the intradermal (id) route. The aim of this study is to evaluate the immunologic response of various age groups of children who received three 2 micrograms id doses of recombinant hepatitis B vaccine. One hundred and eighty-seven children (86 infants, 101 preschool children) were administered a 2 micrograms dose of recombinant hepatitis B vaccine (Gen Hevac B) intradermally zero, one and six months. Eight weeks after the third vaccination, the geometric mean titers (GMT) of antibody to hepatitis B surface antigen (anti-HBs) of infants was 753 IU/L; that of preschool children was 799 IU/L. There was no statistically significant difference between the anti-HBs GMT of infants and preschool children. However, infants were less likely to have developed protective anti-HBs (< or = 10 IU/L) than preschool children (93% vs 100%, p = 0.009). In 8.1 percent of infants and 3.9 percent of preschool children, local reactions were observed. The 2 micrograms recombinant vaccine by id route is safe and suitable for immunization of preschool children. The id route is technically difficult to administrate in infants and protective seroconversion rates are lower than in preschool children.
Download full-text PDF |
Source |
---|
J Med Internet Res
January 2025
School of Clinical Sciences, Monash University, Melbourne, Australia.
Background: eHealth interventions can favorably impact health outcomes and encourage health-promoting behaviors in children. More insight is needed from the perspective of children and their families regarding eHealth interventions, including features influencing program effectiveness.
Objective: This review aimed to explore families' experiences with family-focused web-based interventions for improving health.
J Med Internet Res
January 2025
Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Background: Primary intracranial germ cell tumors (iGCTs) are highly malignant brain tumors that predominantly occur in children and adolescents, with an incidence rate ranking third among primary brain tumors in East Asia (8%-15%). Due to their insidious onset and impact on critical functional areas of the brain, these tumors often result in irreversible abnormalities in growth and development, as well as cognitive and motor impairments in affected children. Therefore, early diagnosis through advanced screening techniques is vital for improving patient outcomes and quality of life.
View Article and Find Full Text PDFNeurology
February 2025
Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, People's Republic of China.
Background And Objectives: Mitochondrial disorders are multiorgan disorders resulting in significant morbidity and mortality. We aimed to characterize death-associated factors in an international cohort of deceased individuals with mitochondrial disorders.
Methods: This cross-sectional multicenter observational study used data provided by 26 mitochondrial disease centers from 8 countries from January 2022 to March 2023.
PLoS One
January 2025
School of Medicine, Institute of Health Science, Jigjiga University, Jigjiga, Ethiopia.
Background: One of the tropical illnesses that is often overlooked is soil-transmitted helminths, or STHs. In tropical and subtropical nations, where poor sanitation and contaminated water sources are common, they mostly impact the most vulnerable populations.
Objective: The aim of this study was to ascertain the prevalence of STHs and related risk factors among the people living in Jigjiga town, Somali region, Eastern Ethiopia.
PLoS One
January 2025
Department of Community Health, Faculty of Clinical Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Background: Nigeria's reproductive, maternal, newborn, child, and adolescent health indicators have remained unsatisfactory in the face of poor-quality healthcare services. Nigeria initiated the reproductive, maternal, newborn, child, and adolescent, elderly + nutrition (RMNCAEH+N) quality of care (QoC) agenda to address the challenge. The health management information system (HMIS) is integral to the agenda but there is sparse evidence on its performance so far.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!